Contract with Customer, Liability, Noncurrent of Evelo Biosciences, Inc. from 31 Dec 2020 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Evelo Biosciences, Inc. quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Dec 2020 to 30 Sep 2023.
  • Evelo Biosciences, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending 30 Sep 2023 was $7,500,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

Evelo Biosciences, Inc. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $7,500,000 $0 0% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $7,500,000 $0 0% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $7,500,000 $0 0% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $7,500,000 $0 0% 31 Dec 2022 10-Q 09 Nov 2023 2023 Q3
Q3 2022 $7,500,000 $0 0% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $7,500,000 $0 0% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $7,500,000 $0 0% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $7,500,000 +$7,500,000 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $7,500,000 30 Sep 2021 10-Q/A 29 Oct 2021 2021 Q3
Q2 2021 $7,500,000 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $7,500,000 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $0 31 Dec 2020 10-Q/A 29 Oct 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.